VivoSim's NAMKind™ Intestine Wins Blue Ribbon Award at Digestive Disease Week Conference
SAN DIEGO, May 13, 2025 (GLOBE NEWSWIRE) -- VivoSim Labs, Inc. (Nasdaq: VIVS) (the 'Company' or 'VivoSim') announced today that its NAMkind™ platform for intestinal efficacy prediction was recognized with a blue ribbon 'Poster of Distinction' award at the Digestive Disease Week Conference (San Diego, CA, May 2-6, 2025). The work describes developing a robust, multicellular in vitro model that closely mirrors human intestinal biology, paving the way for safer and more effective therapies for inflammatory bowel disease (IBD).
The Company's award-winning research showcased a physiologically relevant system built from primary human cells derived from both healthy donors and patients with Ulcerative Colitis or Crohn's Disease. These models exhibit gene expression and phenotypic characteristics that strongly align with native human intestinal tissue, including hallmark features of IBD such as epithelial barrier dysfunction and fibrosis. Importantly, the Company's platform demonstrated responsiveness to clinically used therapeutics, confirming its potential for identifying compounds that promote mucosal healing and prevent stricture formation – two critical goals in IBD treatment. Moreover, the system is showing early promise in distinguishing between older treatments and emerging therapies that may offer improved safety and efficacy,
VivoSim offers liver and intestinal toxicology insights using its premier new approach methodologies (NAM) models, following the announcement of FDA to phase out animal testing requirements in favor of these non-animal NAM methods. The FDA's push to phase out animal models, announced on April 10, is expected to provide a powerful accelerant to VivoSim's market adoption, disrupting a >$10B animal testing market with models that are more predictive and ethically sound.
VivoSim's NAMkind™ intestine model is a physical wet lab model of intestine made using cells from human donors. VivoSim is also developing what it believes will be industry-best in silico predictions of intestinal tox. Artificial intelligence (AI) models in VivoSim's NAMkind™ services suite will be trained on extensive set of proprietary, real-world data from NAM models made from human donor cells, giving much richer and more extensive information than is possible with data from human clinical trials.
VivoSim's NAMkind™ intestine models can also deliver readouts on endpoints that are today not available to industry scientists selecting from many candidate drug molecules. As a result of the lack of such tools, a cancer patient might suffer nausea, vomiting, or intestinal problems, or a patient's needed chemotherapy dose might be lower than it could be due to such conditions. VivoSim aims to provide transformative solutions for these challenges.
The FDA has laid out ambitious goals to phase out animal testing requirements as much as possible. VivoSim is launching to fill in the much-needed gap in commercially available solutions. The technology exists to achieve FDA Commissioner Marty A. Makary's vision, which he expressed in March 2025 with the rollout of FDA's push to move away from animal testing and towards NAM models. 'By leveraging AI-based computational modeling, human organ model-based lab testing, and real-world human data, we can get safer treatments to patients faster and more reliably, while also reducing R&D costs and drug prices,' Makary noted. By leveraging AI-based computational modeling, human organ model-based lab testing, VivoSim is delivering on the promise of this technology, and will use its proprietary methods and cutting-edge capabilities for NAMkind™ models that displace use of animals and provide superior outcomes for its pharmaceutical customers, ultimately delivering better solutions for patients.
Forward Looking Statements
Any statements contained in this press release that do not describe historical facts constitute forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. Any forward-looking statements contained herein are based on current expectations but are subject to a number of risks and uncertainties. Forward-looking statements include statements regarding the Company's expectations that its model paves the way for safer and more effective therapies for IBD and that the models are more predictive and ethically sound, the Company's expectations regarding its market adoption, the Company's belief that it is developing an industry-best in silico predictions of liver tox, the Company's expectations about its AI models in the Company's NAMkind™ services suite, the Company's plan to provide transformative solutions for certain challenges, including that a cancer patient might suffer nausea, vomiting, or intestinal problems, or a patient's needed chemotherapy dose might be lower than it could be and that the Company will deliver on its end goal of providing better solutions for patients. Such forward-looking statements are not guarantees of performance and actual actions or events could differ materially from those contained in such statements. These risks and uncertainties and other factors are identified and described in more detail in the Company's filings with the SEC, including its Annual Report on Form 10-K filed with the SEC on May 31, 2024, as such risk factors are updated in its most recently filed Quarterly Report on Form 10-Q filed with the SEC on February 19, 2025. You should not place undue reliance on these forward-looking statements, which speak only as of the date that they were made. These cautionary statements should be considered with any written or oral forward-looking statements that the Company may issue in the future. Except as required by applicable law, including the securities laws of the United States, the Company does not intend to update any of the forward-looking statements to conform these statements to reflect actual results, later events, or circumstances or to reflect the occurrence of unanticipated events.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
CBC
an hour ago
- CBC
Why don't people want more kids? That's the wrong question, says a new global report
Why aren't people having more kids? What we should actually be asking, according to a new global report, is why so many people feel like they can't. It's often assumed that low fertility rates are due to people simply not wanting to have children, or more than one or two, but a report released Tuesday from the United Nations Population Fund (UNFPA) says that's not the whole picture. "Vast numbers of people are unable to create the families they want," said Dr. Natalia Kanem, UNFPA's executive director, in a news release. That lack of choice "is the real fertility crisis," she said, "and the answer lies in responding to what people say they need: paid family leave, affordable fertility care and supportive partners." The UNFPA report included polling by YouGov. About one in five of the reproductive-aged adults surveyed in 14 different countries said they won't be able to have the number of children they would like, with most saying they would likely have fewer than they wanted, or none at all. The most common barriers were economic, with 39 per cent reporting that financial limitations affected or would affect their ability to realize their desired family size. Other significant barriers included a lack of partner support, low-quality sexual and reproductive health care, a lack of access to services like affordable childcare, and pessimism about the future. The polling surveyed 14,256 adults aged 18 to 88 from 14 countries including the U.S., South Korea, Italy and India between Nov. 15 and Dec. 5, 2024. It didn't mention a margin of error but said most data was nationally representative. While Canada wasn't surveyed, the authors note the sample of countries represents a third of the global population with a mix of incomes and fertility rates. Canadians face barriers, too Previous Statistics Canada data shows a similar trend, with people aged 15 to 49 reporting in 2022 that comparable issues, like affordability, could influence their fertility intentions. And 37 per cent of those polled said they did not believe they could afford to have a child in the next three years. "Many Canadians face structural constraints that prevent them from realizing their fertility aspirations," said Rania Tfaily, an associate professor at Carleton University who studies social demography. The topic recently came up during the federal election campaign when Conservative Leader Pierre Poilievre mentioned that too many young people can't afford to buy homes before their "biological clocks" have run out. But while his wording struck a nerve, his supporters said he highlighted a real concern. In 2022, 32 per cent of Canadians aged 20 to 29 didn't believe they would have access to suitable housing to start a family in the next three years, according to Statistics Canada. Canada recorded its lowest-ever fertility rate for the second year in a row in 2023, according to Statistics Canada data, at 1.26 children born per woman. It joined the ranks of "lowest-low-fertility countries," including South Korea, Spain and Japan. Of course, it's not just a lack of choice driving the rate down — having fewer children is also seen as more desirable today, notes Lisa Strohschein, a sociology professor at the University of Alberta. Statistics Canada data, for instance, consistently reported between 1990 and 2006 that Canadian women intended to have just over two children, on average, Strohschein said. But the most recent estimates from 2022 now suggest the desired number of children overall is 1.5, and that gets even lower with the younger people surveyed. "At the same time, it is the case that women tend to have fewer children than they actually want — even as they want fewer children overall," she said. Reproductive agency goes both ways The UNFPA report emphasizes that reproductive rights go both ways, and so does the global fertility crisis. "It is a crisis in reproductive agency — in the ability of individuals to make their own free, informed and unfettered choices about everything from having sex to using contraception to starting a family," says the report. One in three respondents in the YouGov poll said they or their partner had experienced an unintended pregnancy, for instance, and nearly one in five said they felt pressured to have children when they didn't want to. This can have unintended consequences on the fertility rate, the report noted, especially when policymakers attempt to control reproductive autonomy. For instance, "bans on abortion can lead to individuals voluntarily or involuntarily forgoing reproduction," the report explained. WATCH | This is what an abortion ban looks like in Texas: This is what an abortion ban looks like in Texas 2 years ago Duration 8:27 Texas effectively banned abortion after Roe v. Wade was overturned by the U.S. Supreme Court. CBC's Ellen Mauro travelled to the state to see how people are navigating the restrictions and preparing for them to get worse. A recent study looking at U.S. medical claims found that tubal sterilization and vasectomies increased in the U.S. after among participants ages 19 to 26 after the U.S. Supreme Court overturned Roe v. Wade. If we want people to achieve their desired family size, we need to move away from treating fertility as a means of controlling women's bodies, Strohschein said. Incentives don't work, but what does? Meanwhile, U.S. President Donald Trump says he wants a baby boom, and has mulled incentives to try to convince more people to have children, including so-called baby bonuses. This week, he announced his plan to create tax-deferred investment accounts for babies born in the U.S. over the next four years, starting them each with $1,000, reported The Associated Press. Yet, as the UNFPA report notes, most incentives like this don't work, and can sometimes have the opposite effect. That's because they "are not creating the full range of enabling conditions that people say they need to have families," it states. So what would help people have more children — assuming that's what they want? "Guaranteed affordable and high-quality childcare for all," said Carleton University's Tfaily, as well as economic policies that could reduce people's financial stress, like better worker benefits and more stable jobs. Strohschein had similar suggestions, like making it easier for mothers to return to work after having a baby, as well as affordable childcare. However, "we still have not been all that successful in Canada with either of these two policy levers," she said. "It will be interesting to see whether our national childcare program can change this in the years to come."
CTV News
5 hours ago
- CTV News
CTV National News: Could a trade and security deal with the U.S. happen before the G7?
Watch Vassy Kapelos says steel and aluminum tariffs are what is presently holding up a possible economic and security agreement between Canada and the U.S.
Globe and Mail
6 hours ago
- Globe and Mail
World of EUC: Extraordinary Keynote in End User Computing
The World of EUC has announced an unprecedented keynote for its EUC World Amplify conference, set for August 4-7, 2025, in Minneapolis. Top technical experts from end user computing giants will take the stage for an unfiltered discussion of all things EUC. Charleston, South Carolina--(Newsfile Corp. - June 11, 2025) - The World of EUC (WEUC) has announced an unprecedented keynote panel for its second annual EUC World Amplify conference, scheduled for August 4-7, 2025, in Minneapolis, Minnesota. For the first time, top technical experts from end user computing (EUC) giants will take the stage together for an independent and unfiltered discussion of all things EUC. Extraordinary Keynote in End User Computing To view an enhanced version of this graphic, please visit: Confirmed panelists include: Andrew Morgan from AWS, Shawn Bass from Citrix, Ryan Costello from Google Cloud, Joe Rizkallah from Nutanix, Lokesh Batra from NVIDIA, Christopher Reed from Omnissa, and Christian Aquilina from Parallels. Titled "EUC Tomorrow, Today," the discussion will be moderated by WEUC Director Stephen Wagner. Registration is open at "This will be a real discussion providing real insight with an engaged, in-person community," said Wagner. "These panelists and their companies will shape this industry for the next decade and beyond. This is a huge learning opportunity for every EUC professional out there." The keynote is a live and in-person event. WEUC will not video record or share a transcript. Registration is open at Janna White, WEUC Director, said "Our board has 100 plus years of experience in the industry and we've never seen a panel with so much influence across EUC technologies. We are incredibly proud and grateful to the participants." "It is because of WEUC's independence and the participants' support for a strong EUC community that this is possible," said Jarian Gibson, WEUC Chairperson. "These panelists are smart. You can count on great insights. Let's Go!" WEUC is a nonprofit founded in 2024 to cultivate a thriving community where EUC professionals share insights, foster collaboration, and build connections. WEUC is an independent, inclusive and vendor-agnostic platform. Learn more here: EUC World Amplify is WEUC's 2025 in-person event drawing EUC professionals, vendors and channel partners from around the world. Learn more here: To view the source version of this press release, please visit
